• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Ajit Gill takes over for John Santini as the top man at MicroCHIPS

April 13, 2010 By drugdelivery

MicroCHIPS logo

As MicroCHIPS Inc. prepares to leave the laboratory and enter clinical development, the company is bringing in a new CEO to replace outgoing co-founder John Santini.

The Bedford, Mass.-based drug delivery systems developer tapped Ajit Gill, the former CEO of Auspex Pharmaceuticals and Nektar Therapeutics, for its corner office. In addition to his duties as president and CEO, Gill will also sit on the company’s board of directors.

Santini, a former graduate assistant of MIT legend Robert Langer, founded MicroCHIPS along with Langer and MIT colleague Michael Cima in 1999. He led the firm for 11 years, through several funding rounds, including a recent nearly $16.5 million raise that took the total to $70 million.

Santini moves on to front On Demand Therapeutics Inc., a San Francisco-based MicroCHIPS spinout that’s still in stealth mode. Santini told the Boston Globe in January that part of MicroCHIP’s recent funding round was going towards developing On Demand, which is focused on delivering drugs to the eye.

MicroCHIPS says it’s moving closer to clinical trials on two of its products this year. The first is an implant for continuous glucose monitoring for people with diabetes; the second is an implantable device designed to deliver “an anabolic bone-building therapy for severe osteoporosis,” according to a press release.

Filed Under: Business/Financial News, Diagnostics, Drug-Device Combinations Tagged With: MicroCHIPS Inc.

IN CASE YOU MISSED IT

  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development
  • Ypsomed brings autoinjector for dual GCG/GLP-1 delivery to China
  • Convatec wins FDA approval for Parkinson’s treatment infusion tech

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS